𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN26 COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF SUNITINIB VS SORAFENIB AND BEVACIZUMAB + INTERFERON-ALFA AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN MEXICO

✍ Scribed by Salinas-Escudero, G; Contreras-Hernandez, I; Mould-Quevedo, J


Book ID
122703061
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
64 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES